Katia Hamidouche

Novel Multitarget-Directed Ligands (MTDLs) with Acetylcholinesterase (AChE) Inhibitory and Serotonergic Subtype 4 Receptor (5-HT₄R) Agonist Activities As Potential Agents against Alzheimer’s Disease: The Design of Donecopride

Christophe Rochais, Cédric Lecoutey, Florence Gaven et al. · Journal of Medicinal Chemistry · 2015 · 114 citations · Full text

Drug Target, Serotonergic Subtype 4, Neurochemical Biomarkers +19

Chronic activation of 5-HT4 receptors or blockade of 5-HT6 receptors improve memory performances

Anne Quiedeville, Michel Boulouard, Katia Hamidouche et al. · Behavioural Brain Research · 2015 · 46 citations

Storage (Memory), Memory System, Chronic Activation +10

Design, synthesis, and pharmacological evaluation of multitarget-directed ligands with both serotonergic subtype 4 receptor (5-HT4R) partial agonist and 5-HT6R antagonist activities, as potential treatment of Alzheimer’s disease

Samir Yahiaoui, Katia Hamidouche, Céline Ballandonne et al. · European Journal of Medicinal Chemistry · 2016 · 40 citations · Full text

Neurodegenerative Diseases, Alzheimer's Disease, Medicine +10

Donecopride, a Swiss army knife with potential against Alzheimer's disease

Christophe Rochais, Cédric Lecoutey, Katia Hamidouche et al. · British Journal of Pharmacology · 2019 · 31 citations · Full text

Co-modulation of an allosteric modulator of nicotinic receptor-cholinesterase inhibitor (galantamine) and a 5-HT4 receptor agonist (RS-67333): effect on scopolamine-induced memory deficit in the mouse

Thomas Fréret, Véronique Lelong‐Boulouard, Pierre Lecouflet et al. · Psychopharmacology · 2017 · 16 citations

Nicotinic Receptor-cholinesterase Inhibitor, Medicine, Nicotine +7